The document discusses prothrombin time (PT) and partial thromboplastin time (PTT) tests, which measure how quickly blood clots. PT specifically measures the extrinsic clotting pathway efficiency, while PTT measures the intrinsic pathway. The tests are used to detect bleeding disorders, monitor blood thinners, and assess bleeding risk before surgery. The procedure incubates plasma with thromboplastin and calcium chloride, then measures clotting time in seconds. Normal PT is 12-15 seconds, while the international normalized ratio ranges from 1.0-1.2. High PT can indicate liver disease, vitamin K deficiency, or a genetic clotting disorder.